XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2023
STOCK-BASED COMPENSATION  
SCHEDULE OF OPTION ACTIVITY UNDER 2021 PLAN AND 2018 PLAN

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted-

    

​

​

 

​

​

​

​

​

​

​

Average

​

​

​

 

​

​

​

​

​

​

​

Remaining

​

Aggregate

 

​

​

​

​

Weighted-Average

​

Contractual Term

​

Intrinsic Value

 

​

    

Options

    

Exercise Price

    

(in years)

    

(in thousands)

 

Vested and expected to vest at December 31, 2022

 

4,110,219

​

$

9.23

 

8.46

​

$

82,490

​

Granted

 

1,158,501

​

​

25.01

 

​

​

​

  

​

Exercised

 

(93,966)

​

​

2.37

 

  

​

 

  

​

Cancelled/Forfeited

 

(66,889)

​

​

6.28

 

  

​

 

  

​

Outstanding at March 31, 2023

 

5,107,865

​

$

12.97

​

8.72

​

​

42,611

​

Vested and exercisable at March 31, 2023

 

1,242,496

​

​

8.41

​

8.03

​

​

14,718

​

Vested and expected to vest at March 31, 2023

 

5,107,865

​

​

12.97

​

8.72

​

​

42,611

​

​

SCHEDULE OF UNVESTED STOCK UNIT ACTIVITY

​

​

​

​

​

​

​

​

​

    

  

    

Weighted-

 

​

​

​

​

Average Grant

 

​

​

​

​

Date Fair Value

 

​

​

Units

​

Per Unit

 

Unvested restricted stock units as of December 31, 2022

 

28,881

 

​

—

​

Granted

 

3,000

​

$

24.58

​

Vested

 

—

​

 

—

​

Forfeited

 

—

​

 

—

​

Unvested restricted stock units as of March 31, 2023

 

31,881

​

$

21.90

​

​

SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTIONS

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

​

​

  

2023

​

2022

  

 

Expected term (in years)

 

5.3 - 6.1

 

5.3 - 6.1

 

​

Expected volatility

 

74.08 - 76.71

%  

73.64 - 75.68

%

​

Risk-free interest rate

 

3.46 - 4.28

%  

1.37 - 2.55

%

​

Expected dividend

 

—

 

—

​

 

​

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION GRANTS

Stock-based compensation expense recognized for all equity awards has been reported in the statements of operations and comprehensive loss as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

    

Three Months Ended March 31, 

​

​

    

2023

    

2022

 

Research and development

​

$

1,299

​

$

768

​

General and administrative

​

​

1,085

​

​

256

​

Total

​

$

2,384

​

$

1,024

​

​

​

​

​

​

Stock-based compensation expense by type of award included within the consolidated statements of operations and comprehensive income (loss) was as follows:

​

​

​

​

​

​

​

​

​

    

Three Months Ended March 31, 

​

​

    

2023

    

2022

​

Stock options

​

$

2,289

​

$

1,024

​

Restricted stock awards and units

​

​

48

​

​

—

​

Employee stock purchase plan awards

​

​

47

​

​

—

​

Total

​

$

2,384

​

$

1,024

​

​